MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.37 Million CAD | 22.1% |
| 2022 | -3.81 Million CAD | 15.39% |
| 2021 | -4.54 Million CAD | -52.91% |
| 2020 | -2.94 Million CAD | 1.48% |
| 2019 | -3.01 Million CAD | 24.84% |
| 2018 | -3.98 Million CAD | -186.09% |
| 2017 | -1.38 Million CAD | -24.86% |
| 2016 | -1.16 Million CAD | -74.98% |
| 2015 | -637.38 Thousand CAD | -23.77% |
| 2014 | -514.97 Thousand CAD | 41.84% |
| 2013 | -885.43 Thousand CAD | 30.81% |
| 2012 | -1.27 Million CAD | -63.01% |
| 2011 | -688.62 Thousand CAD | 18.7% |
| 2010 | -965.64 Thousand CAD | 61.67% |
| 2009 | -2.51 Million CAD | 4.62% |
| 2008 | -2.64 Million CAD | -57.78% |
| 2007 | -1.67 Million CAD | -56.39% |
| 2006 | -1.23 Million CAD | 33.29% |
| 2005 | -1.6 Million CAD | -692.24% |
| 2004 | -202.54 Thousand CAD | 76.09% |
| 2003 | -847.26 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -724.6 Thousand CAD | 1.9% |
| 2024 Q1 | -738.62 Thousand CAD | -18.97% |
| 2023 FY | - CAD | 22.1% |
| 2023 Q4 | -620.84 Thousand CAD | 24.82% |
| 2023 Q2 | -773.16 Thousand CAD | -1.62% |
| 2023 Q1 | -760.82 Thousand CAD | 21.65% |
| 2023 Q3 | -825.76 Thousand CAD | -6.8% |
| 2022 FY | - CAD | 15.39% |
| 2022 Q2 | -1.01 Million CAD | -4.7% |
| 2022 Q4 | -971.05 Thousand CAD | -12.18% |
| 2022 Q1 | -967.23 Thousand CAD | 12.38% |
| 2022 Q3 | -865.63 Thousand CAD | 14.52% |
| 2021 FY | - CAD | -52.91% |
| 2021 Q4 | -1.1 Million CAD | 19.77% |
| 2021 Q1 | -923.46 Thousand CAD | -46.72% |
| 2021 Q2 | -1.1 Million CAD | -19.92% |
| 2021 Q3 | -1.37 Million CAD | -24.25% |
| 2020 FY | - CAD | 1.48% |
| 2020 Q1 | -582.89 Thousand CAD | 47.75% |
| 2020 Q4 | -629.42 Thousand CAD | 40.87% |
| 2020 Q2 | -671.94 Thousand CAD | -15.28% |
| 2020 Q3 | -1.06 Million CAD | -58.41% |
| 2019 Q2 | -653.85 Thousand CAD | 8.47% |
| 2019 Q3 | -510.3 Thousand CAD | 21.95% |
| 2019 FY | - CAD | 24.84% |
| 2019 Q4 | -1.11 Million CAD | -118.62% |
| 2019 Q1 | -714.38 Thousand CAD | 27.44% |
| 2018 Q3 | -863.67 Thousand CAD | 43.28% |
| 2018 Q4 | -984.59 Thousand CAD | -14.0% |
| 2018 FY | - CAD | -186.09% |
| 2018 Q1 | -612.97 Thousand CAD | -150.5% |
| 2018 Q2 | -1.52 Million CAD | -148.42% |
| 2017 Q4 | -244.69 Thousand CAD | 51.36% |
| 2017 Q1 | -290.99 Thousand CAD | -15.96% |
| 2017 Q2 | -353.83 Thousand CAD | -21.59% |
| 2017 FY | - CAD | -24.86% |
| 2017 Q3 | -503.06 Thousand CAD | -42.18% |
| 2016 Q2 | -261.4 Thousand CAD | -48.23% |
| 2016 Q1 | -176.35 Thousand CAD | 50.26% |
| 2016 Q3 | -423.04 Thousand CAD | -61.84% |
| 2016 FY | - CAD | -74.98% |
| 2016 Q4 | -250.93 Thousand CAD | 40.68% |
| 2015 FY | - CAD | -23.77% |
| 2015 Q1 | -34.48 Thousand CAD | 90.94% |
| 2015 Q4 | -354.53 Thousand CAD | -65.84% |
| 2015 Q3 | -213.78 Thousand CAD | -524.22% |
| 2015 Q2 | -34.24 Thousand CAD | 0.69% |
| 2014 FY | - CAD | 41.84% |
| 2014 Q3 | 356.7 Thousand CAD | 230.76% |
| 2014 Q2 | -272.79 Thousand CAD | -25.12% |
| 2014 Q1 | -218.03 Thousand CAD | -176.7% |
| 2014 Q4 | -380.84 Thousand CAD | -206.77% |
| 2013 Q1 | -289.95 Thousand CAD | 15.59% |
| 2013 Q4 | -78.79 Thousand CAD | 79.55% |
| 2013 FY | - CAD | 30.81% |
| 2013 Q2 | -131.32 Thousand CAD | 54.71% |
| 2013 Q3 | -385.35 Thousand CAD | -193.45% |
| 2012 FY | - CAD | -63.01% |
| 2012 Q4 | -343.52 Thousand CAD | -8.01% |
| 2012 Q3 | -318.04 Thousand CAD | 7.01% |
| 2012 Q2 | -342.01 Thousand CAD | -11.08% |
| 2012 Q1 | -307.9 Thousand CAD | -108.73% |
| 2011 Q4 | -147.51 Thousand CAD | 42.78% |
| 2011 Q2 | -174.78 Thousand CAD | 14.68% |
| 2011 Q1 | -204.84 Thousand CAD | -14.47% |
| 2011 FY | - CAD | 18.7% |
| 2011 Q3 | -257.8 Thousand CAD | -47.49% |
| 2010 Q1 | -246.49 Thousand CAD | 78.78% |
| 2010 FY | - CAD | 61.67% |
| 2010 Q2 | -275.24 Thousand CAD | -11.66% |
| 2010 Q3 | -300.31 Thousand CAD | -9.11% |
| 2010 Q4 | -178.95 Thousand CAD | 40.41% |
| 2009 Q2 | -530.4 Thousand CAD | -15.87% |
| 2009 Q1 | -457.74 Thousand CAD | 25.34% |
| 2009 FY | - CAD | 4.62% |
| 2009 Q3 | -369.6 Thousand CAD | 30.32% |
| 2009 Q4 | -1.16 Million CAD | -214.25% |
| 2008 Q4 | -613.07 Thousand CAD | 2.7% |
| 2008 Q3 | -630.07 Thousand CAD | 18.89% |
| 2008 Q1 | -621.27 Thousand CAD | -69.58% |
| 2008 Q2 | -776.81 Thousand CAD | -25.04% |
| 2008 FY | - CAD | -57.78% |
| 2007 Q2 | -483.74 Thousand CAD | 9.27% |
| 2007 Q1 | -533.2 Thousand CAD | -16.35% |
| 2007 Q3 | -289.92 Thousand CAD | 40.07% |
| 2007 Q4 | -366.35 Thousand CAD | -26.36% |
| 2007 FY | - CAD | -56.39% |
| 2006 Q2 | -124.18 Thousand CAD | -98.01% |
| 2006 Q1 | -62.71 Thousand CAD | 92.05% |
| 2006 FY | - CAD | 33.29% |
| 2006 Q3 | -524.01 Thousand CAD | -321.96% |
| 2006 Q4 | -458.29 Thousand CAD | 12.54% |
| 2005 Q4 | -788.45 Thousand CAD | -75.64% |
| 2005 FY | - CAD | -692.24% |
| 2005 Q1 | -149.91 Thousand CAD | 14.46% |
| 2005 Q2 | -154.54 Thousand CAD | -3.09% |
| 2005 Q3 | -448.91 Thousand CAD | -190.47% |
| 2004 FY | - CAD | 76.09% |
| 2004 Q1 | -94.66 Thousand CAD | 0.0% |
| 2004 Q3 | -49.77 Thousand CAD | -130.81% |
| 2004 Q4 | -175.25 Thousand CAD | -252.14% |
| 2004 Q2 | 161.51 Thousand CAD | 270.62% |
| 2003 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| IR-Med Inc. | -4.89 Million USD | 51.375% |
| BioElectronics Corporation | -274.29 Thousand USD | -767.228% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 621.58% |
| CVR Medical Corp. | - USD | Infinity% |
| Össur hf. | 137.38 Million USD | 101.731% |
| Polarean Imaging plc | -11.19 Million USD | 78.752% |
| Avitar, Inc. | -1.66 Million USD | -42.626% |
| AVITA Medical, Inc. | -39.56 Million USD | 93.988% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -104.357% |
| Zecotek Photonics Inc. | -3.44 Million USD | 30.896% |
| QHSLab, Inc. | -91.29 Thousand USD | -2505.589% |
| Wellstar International, Inc. | -1.35 Million USD | -75.355% |
| Össur hf. | 137.38 Million USD | 101.731% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 124.337% |
| Escalon Medical Corp. | -58.46 Thousand USD | -3968.901% |
| Aurora Spine Corporation | -454.37 Thousand USD | -423.511% |
| BrainsWay Ltd. | -2.31 Million USD | -2.93% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 74.639% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 143.08% |
| Vivos Inc. | -2.79 Million USD | 14.837% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.316% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1103.252% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -42.562% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -527.786% |
| Nanomix Corporation | -8.13 Million USD | 70.777% |
| Theraclion SA | -2.05 Million USD | -15.991% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -236.438% |
| Positron Corporation | -1.45 Million USD | -63.807% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -38.146% |
| Lombard Medical, Inc. | -28.06 Million USD | 91.525% |
| ALR Technologies Inc. | -6.4 Million USD | 62.834% |
| Stratec SE | 39.91 Million USD | 105.96% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 2456.498% |
| Heart Tronics, Inc. | -14.85 Million USD | 83.989% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -1911.449% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 82.084% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 74.009% |
| VMS Rehab Systems, Inc. | -68.55 USD | -3469951.058% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 23.905% |
| Ingen Technologies, Inc. | -8639.00 USD | -27434.668% |
| Odyssey Group International, Inc. | -2.13 Million USD | -11.255% |
| United American Healthcare Corporation | -59 Thousand USD | -3931.729% |
| ECGI Holdings, Inc. | -2.99 Million USD | 20.456% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -278.065% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -362.763% |
| Urologix, Inc. | -6.34 Million USD | 62.504% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -91.931% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -210.551% |
| SS Innovations International, Inc. | -20.37 Million USD | 88.326% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -967.562% |
| Smith & Nephew plc | 1 Billion USD | 100.237% |
| NIOX Group Plc | 11.07 Million USD | 121.478% |
| Fuse Medical, Inc. | 1.83 Million USD | 229.608% |
| Broncus Holding Corporation | -25.19 Million USD | 90.56% |
| Brain Scientific Inc. | -7.93 Million USD | 70.018% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 74.67% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -12827.826% |